AAAAAA
Results:
1-13
|
Results: 13
Authors:
Hidalgo, M
Siu, LL
Nemunaitis, J
Rizzo, J
Hammond, LA
Takimoto, C
Eckhardt, SG
Tolcher, A
Britten, CD
Denis, L
Ferrante, K
Von Hoff, DD
Silberman, S
Rowinsky, EK
Citation: M. Hidalgo et al., Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies, J CL ONCOL, 19(13), 2001, pp. 3267-3279
Authors:
Tolcher, AW
Eckhardt, SG
Kuhn, J
Hammond, L
Weiss, G
Rizzo, J
Aylesworth, C
Hidalgo, M
Patnaik, A
Schwartz, G
Felton, S
Campbell, E
Rowinsky, EK
Citation: Aw. Tolcher et al., Phase I and pharmacokinetic study of NSC 655649, a rebeccamycin analog with topoisomerase inhibitory properties, J CL ONCOL, 19(11), 2001, pp. 2937-2947
Authors:
Rizzo, J
Citation: J. Rizzo, Apple power mac G4 (dual 500MHz), FORTUNE, 143(13), 2001, pp. 133-133
Authors:
Brooks, A
Ekleberry, A
McMahon, J
Begle, R
Johnson, M
Rizzo, J
Zervos, MJ
Citation: A. Brooks et al., Evaluation of clinical practice guidelines on outcome of infection in medical intensive care unit patients, INF DIS C P, 9(8), 2000, pp. 339-348
Authors:
Tolcher, AW
Aylesworth, C
Rizzo, J
Izbicka, E
Campbell, E
Kuhn, J
Weiss, G
Von Hoff, DD
Rowinsky, EK
Citation: Aw. Tolcher et al., A phase I study of rhizoxin (NSC 332598) by 72-hour continuous intravenousinfusion in patients with advanced solid tumors, ANN ONCOL, 11(3), 2000, pp. 333-338
Authors:
Rowinsky, EK
Johnson, TR
Geyer, CE
Hammond, LA
Eckhardt, SG
Drengler, R
Smetzer, L
Coyle, J
Rizzo, J
Schwartz, G
Tolcher, A
Von Hoff, DD
De Jager, RL
Citation: Ek. Rowinsky et al., DX-8951f, a hexacyclic camptothecin analog, on a daily times-five schedule: A phase I and pharmacokinetic study in patients with advanced solid malignancies, J CL ONCOL, 18(17), 2000, pp. 3151-3163
Authors:
Jackson, BG
Pedersen, SW
Fisher, JW
Misner, JW
Gardner, JP
Staszak, MA
Doecke, C
Rizzo, J
Aikins, J
Farkas, E
Trinkle, KL
Vicenzi, J
Reinhard, M
Kroeff, EP
Higginbotham, CA
Gazak, RJ
Zhang, TY
Citation: Bg. Jackson et al., Enantioselective syntheses of 1-carbacephalosporins from chemoenzymically derived beta-hydroxy-alpha-amino acids: Applications to the total synthesisof carbacephem antibiotic loracarbef, TETRAHEDRON, 56(31), 2000, pp. 5667-5677
Authors:
Rizzo, J
Harris, FW
Citation: J. Rizzo et Fw. Harris, Synthesis and thermal properties of fluorosilicones containing perfluorocyclobutane rings, POLYMER, 41(13), 2000, pp. 5125-5136
Authors:
Rizzo, J
Bernstein, D
Gress, F
Citation: J. Rizzo et al., A performance, safety and cost comparison of reusable and disposable endoscopic biopsy forceps: a prospective, randomized trial, GASTROIN EN, 51(3), 2000, pp. 257-261
Authors:
Brooks, A
Ekleberry, A
McMahon, J
Begle, R
Johnson, M
Rizzo, J
Zervos, MJ
Citation: A. Brooks et al., Evaluation of clinical practice guidelines on outcome of infection in medical intensive care unit patients, INF DIS C P, 8(2), 1999, pp. 97-106
Authors:
Walton, GD
Schreeder, MT
Rizzo, J
Jobe, DR
Kuhn, J
Citation: Gd. Walton et al., Hepatic artery administration of paclitaxel, CANCER INV, 17(2), 1999, pp. 118-120
Authors:
Eckhardt, SG
Rizzo, J
Sweeney, KR
Cropp, G
Baker, SD
Kraynak, MA
Kuhn, JG
Villalona-Calero, MA
Hammond, L
Weiss, G
Thurman, A
Smith, L
Drengler, R
Eckardt, JR
Moczygemba, J
Hannah, AL
Von Hoff, DD
Rowinsky, EK
Citation: Sg. Eckhardt et al., Phase I and pharmacologic study of the tyrosine kinase inhibitor SU101 in patients with advanced solid tumors, J CL ONCOL, 17(4), 1999, pp. 1095-1104
Authors:
Rizzo, J
Bernstein, D
Gress, F
Citation: J. Rizzo et al., A randomized double-blind placebo-controlled trial evaluating the cost-effectiveness of droperidol as a sedative premedication for EUS, GASTROIN EN, 50(2), 1999, pp. 178-182
Risultati:
1-13
|